论文部分内容阅读
2011年11月,国际心脑血管病交流会上,160位心脑血管领域的国内外专家学者,围绕我国自主研发的心脑血管药品“通脉方”展开了讨论研究,最终得出一致结论:通脉方急能治标,缓能治本!该药首个实现了心、脑、血管同治,肝、肾、脾、胃同养,治养结合。溶栓药、扩张血管药,为何吃上就停不了?为何吃了这些药,反而频繁引发猝死、脑溢血,危及生命?最近,一篇题为“拿生命赌健康”的文章,为心脑血管病患者敲响了警钟!气血不足是心脑血管病的早期病机。气为血帅,气行则血行,气滞则
In November 2011, at the International Conference on Cardiovascular Diseases, 160 domestic and foreign experts and scholars in the field of cardiovascular and cerebrovascular medicine started discussions and discussions around the cardiovascular and cerebrovascular medicines independently developed in China, and finally concluded Unanimous conclusion: Tongmai Fangmai can stop the symptoms and relieve the symptoms. The medicine first achieves the heart, brain and blood vessels to have the same treatment. Thrombolytics, dilated blood vessels, why eat can not stop? Why eat these drugs, but frequently lead to sudden death, stroke, life-threatening? Recently, an article entitled Patients with cerebrovascular disease sounded the alarm! Insufficiency of blood and cerebrovascular disease is an early pathogenesis. Gas for the handsome blood, gas is the blood line, Qi stagnation